-
-
-
According to new data from the Centers for Disease Control and Prevention's (CDC's) 2013 National Immunization Survey Teen, the number of girls and boys ages 13-17 years receiving human papillomavirus (HPV) vaccine remains unacceptably low, despite a slight increase in vaccination coverage since 2012.
-
Availability of emergency contraception (EC) has broadened since the FDA ruled that generic EC could be sold on store shelves and would no longer require proof of age.
-
Data presented at the AIDS 2014 international conference indicates that oral HIV pre-exposure prophylaxis (PrEP) provides a high degree of protection against HIV infection, even for individuals who miss some daily doses.
-
Science is looking at a wireless microchip implant, with remote drug delivery control, that is designed to last up to 16 years.
-
Presentations at the AIDS 2014 conference offer differing outlooks on increased risk of HIV in women using contraceptive injections.
-
Long-acting reversible contraception (LARC) — the copper T and levonorgestrel intrauterine devices (IUDs) and the birth control implant — are the most effective reversible methods available to prevent unintended pregnancy. They last for several years and are easy to use. Clinicians can draw lessons from the Contraceptive CHOICE project in St. Louis on how to make their clinics "LARC First.
-
Think about the last five women who have entered your examination room. How many of them have had genital herpes simplex virus Type 2 (HSV-2) infection?
-
How can Hispanic men be reached with an HIV prevention message? It's time to spread the word. While Hispanics/Latinos comprise 15% of the U.S. population, they accounted for 17% of all new HIV infections occurring in the United States in 2006.
